What's breaking now, across thousands of outlets.
Nature, Published online: 14 September 2026; doi:10.1038/d41586-026-02882-x An AI system trained on more than 20,000 protein structures from pharmaceutical companies outperforms AlphaFold-like models that use only public data.
We haven't written up this one. Nature has the full story — the link below goes straight to it.
New correspondent Ross Douthat says "no story looms larger than the latest developments in artificial intelligence." The technology and its impacts will be a major focus of 60 Minutes reporting.
TLDR: AI has made prototypes, POCs and MVPs cheap — a plausible demo in days. What has not gotten cheaper is everything after: reliability, adoption, governance, cost-to-serve.
While I have grown tired of his endless proclamations, Dario Amodei does raise points that will impact many stocks if the spending curb proceeds.
China’s top intelligence official has warned of rising national security risks posed by artificial intelligence (AI), calling for robust risk prevention frameworks and stronger global governance of the emerging technology.
China’s top intelligence official has warned of rising national security risks posed by artificial intelligence (AI), calling for robust risk prevention frameworks and stronger global governance of the emerging technology.
A Quick Look at the Finding A group of researchers just released a paper titled Stealing Reasoning Traces from Proprietary LLM APIs (see the original site here ). In short, they show that when you call a commercial large‑language model (LLM) like Claude, GPT‑4, or Gemini, the service often returns encrypted “chain‑of‑thought” blocks .
